Chemical Name: | (3aR,4R,9bS)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline |
References: | Dennis, M. K., Burai, R., Ramesh, C., Petrie, W. K., Alcon, S. N., Nayak, T. K., ... & Prossnitz, E. R. (2009). In vivo effects of a GPR30 antagonist.Nature chemical biology,5(6), 421-427. Ariazi, E. A., Brailoiu, E., Yerrum, S., Shupp, H. A., Slifker, M. J., Cunliffe, H. E., ... & Jordan, V. C. (2010). The G protein–coupled receptor GPR30 inhibits proliferation of estrogen receptor–positive breast cancer cells.Cancer research,70(3), 1184-1194. Hammond, R., & Gibbs, R. B. (2011). GPR30 is positioned to mediate estrogen effects on basal forebrain cholinergic neurons and cognitive performance.Brain research,1379, 53-60. |